Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Claudel

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|March 1, 2013
Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradoxThierry Claudel, Michael Trauner
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2013
Editorial for 'randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis'Tatjana Stojakovic, Thierry Claudel, Michael Trauner
Seminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael Trauner
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael Trauner
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2005
The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolismThierry Claudel, Bart Staels, Folkert Kuipers
Journal of Hepatology|August 14, 2012
Bile acid transporters and regulatory nuclear receptors in the liver and beyondEmina Halilbasic, Thierry Claudel, Michael Trauner
Trends in Endocrinology and Metabolism: TEM|September 4, 2014
Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLDClaudia D Fuchs, Thierry Claudel, Michael Trauner
Journal of Hepatology|March 7, 2025
Reply to "Pharmacological inhibition of ATGL as therapeutic approach for MASH: Far beyond the lipase suppressing role of ATGL inhibitors"Emmanuel Dauda Dixon, Thierry Claudel, Michael Trauner
Biochimica Et Biophysica Acta|January 4, 2011
Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone diseaseThierry Claudel, Gernot Zollner, Martin Wagner, et al.
Reviews in Endocrine & Metabolic Disorders|October 16, 2004
The Farnesoid X Receptor (FXR) as modulator of bile acid metabolismFolkert Kuipers, Thierry Claudel, Ekkehard Sturm, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|March 1, 2013
Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradoxThierry Claudel, Michael Trauner
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2013
Editorial for 'randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis'Tatjana Stojakovic, Thierry Claudel, Michael Trauner
Seminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael Trauner
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael Trauner
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2005
The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolismThierry Claudel, Bart Staels, Folkert Kuipers
Journal of Hepatology|August 14, 2012
Bile acid transporters and regulatory nuclear receptors in the liver and beyondEmina Halilbasic, Thierry Claudel, Michael Trauner
Trends in Endocrinology and Metabolism: TEM|September 4, 2014
Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLDClaudia D Fuchs, Thierry Claudel, Michael Trauner
Journal of Hepatology|March 7, 2025
Reply to "Pharmacological inhibition of ATGL as therapeutic approach for MASH: Far beyond the lipase suppressing role of ATGL inhibitors"Emmanuel Dauda Dixon, Thierry Claudel, Michael Trauner
Biochimica Et Biophysica Acta|January 4, 2011
Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone diseaseThierry Claudel, Gernot Zollner, Martin Wagner, et al.
Reviews in Endocrine & Metabolic Disorders|October 16, 2004
The Farnesoid X Receptor (FXR) as modulator of bile acid metabolismFolkert Kuipers, Thierry Claudel, Ekkehard Sturm, et al.
Pageof 8